The objective of this study was to analyse parameters in rhesus monkey collagen-induced arthritis (CIA) with which the inflammation and destruction of the joints can be described in quantitative terms. CIA was induced in genetically susceptible and resistant monkeys, which can be distinguished on the basis of the dominant resistance marker Mamu-A26. The disease course was monitored daily using a semiquantitative scoring system. Plasma samples were collected once or twice weekly and analysed for C-reactive protein (CRP). Urines were collected overnight once a week and analysed for excretion rates of the collagen cross-links hydroxylysylpyridinoline (HP) and lysylpyridinoline (LP). The results show that periods of active CIA are characterized by substantial weight loss and increased plasma CRP levels, followed shortly thereafter by increased excretion rates of the collagen cross-links HP and LP. Remission of the disease can be recognized by a decline in plasma CRP levels and especially an increase in body weight. The highest CRP levels were found in the most severely arthritic monkeys, indicating a possible relationship of the absolute plasma CRP levels to the severity of inflammation. During periods of active arthritis, increased excretion rates of collagen cross-links HP and LP in the urine were found. In particular, the major collagen crosslink in articular cartilage, HP, showed a strong increase (9-to 15-fold ). The excretion rates of LP, which is considered as a bone-specific degradation marker, only increased 4-to 6-fold, thus indicating predominant destruction of cartilage and less of bone. In conclusion, the severity of CIA can be monitored in a quantitative manner using plasma CRP levels, urinary excretion rates of HP and LP, and body weights, superimposed on semiquantitative clinical scores. The parameters also facilitate a more objective assessment of the effect of anti-arthritic drugs in the model than with the clinical scores alone.
I of rhesus monkeys with bovine type II However, they are too inaccurate for comparison of the disease severity between different experimental collagen (CII ) induces a self-limiting monophasic polyarthritis, known as collagen-induced arthritis (CIA).
groups. For objective efficacy evaluation of antiarthritic drugs in the model, quantitative disease paraThis experimentally induced autoimmune disease shows several similarities with human arthritides [1] [2] [3] .
meters are needed.
The results of our study show that periods of active Over the past few years, disease models in non-human primates have become increasingly important for safety arthritis are characterized by substantial loss of body weight, increased plasma concentrations of C-reactive and efficacy evaluation of new therapeutic modalities that cannot be tested in rodents [4] . The therapeutic protein (CRP) and higher urinary excretion rates of the major collagen cross-links hydroxylysylpyridinoline activity and adverse side-effects of biological molecules depend on functional interaction with their target (HP) and lysylpyridinoline (LP) present in the various joint tissues. The validity of these parameters as quantantigen. The poor reactivity of most human biologicals with the relevant target structures in rodent species itative indicators of CIA, in particular of inflammation and joint destruction, is discussed. makes disease models in rodents invalid in this respect. The phylogenetic relationship and consequent immunological similarity [6] [7] [8] [9] [10] [11] between man and MATERIALS AND METHODS rhesus monkey makes this non-human primate CIA Animals model an attractive test system for human-specific
The rhesus monkeys (Macaca mulatta) that have biological molecules with anti-rheumatic potential.
been used in this study were housed at the Biomedical For the clinical evaluation of the severity of arthritis, Primate Research Centre (Rijswijk, The Netherlands). a semiquantitative scoring system has been used, which All monkeys have been genotyped for class I (Mamuis based on the degree of inflammation and deforma-A and -B) and II (Mamu-DR) antigens as described tion of the affected joints [5] . These semiquantitative previously [11] . The essential data of all monkeys are clinical parameters are very useful for longitudinal summarized in Table I . CIA-susceptible monkeys were monitoring of the CIA course in individual monkeys.
selected based on the lack of the MHC class I allele Mamu-A26 which seems to act as a dominant genetic marker for resistance to CIA in rhesus monkeys [12] . Monkeys in the experiment were observed daily for taken to cluster only those monkeys which were in similar types of experiments during about the same changes in behaviour, food intake and general appearance. When necessary for handling, the animals were time period. sedated with 0.1 mg/kg ketamine (10 mg/ml; Chassot & Cie AG, Bern, Switzerland ). During the studies, the Arthritis induction CIA was evoked by immunization with 1-3 mg type monkeys received a standard diet of food pellets (Hope Farms) supplemented with rice and fruits or vegetables II collagen (b-CII ) from bovine hyaline cartilage. The arthritogenicity of each newly isolated batch was rouin season. Drinking water was provided ad libitum.
For the purpose of this study, new and historical tinely tested in WAG/Rij rats (RT-1u) as described elsewhere [14] . b-CII was dissolved to a clear solution data, collected over the past 9 yr, have been grouped to show a relationship between clinical evaluation, in 0.1  acetic acid to 6 mg/ml and then emulsified in an equal volume of complete Freund's adjuvant. Each joint inflammation and destruction of joint tissues along with the histology of affected joints. The original monkey was injected intracutaneously on the back with 1 ml of the emulsion, which was distributed over literature references for animals which were part of previous studies are given in Table I Clinical evaluation. Apparent symptoms of arthritis, (10 nmol/ml ) and homoarginine (2.4 mmol/ml ). The hydrolysates were analysed for their hydroxyproline such as soft-tissue swelling and redness of affected joints, were diagnosed under the supervision of a content after derivatization with 9-fluorenylmethyl chloroformate; the levels of HP and LP were measured trained veterinarian and scored on a modified version of the arbitrary scale published previously [5] : 0 = no with the chromatographic system described above (excluding the solid-phase extraction step). Values are disease symptoms; 0.5 = fever; 1 = apathy and loss of appetite, weight loss; 2 = weight loss, warm joints with expressed as picomoles of HP and picomoles of LP pain, no apparent joint swelling; 3 = moderate softtissue swelling, but normal flexibility of affected joints; 4 = severe soft-tissue swelling with joint stiffness; 5 = such severe disease that euthanasia is necessary. Each time the monkeys were sedated for other purposes, they were weighed and the body temperature was recorded.
Inflammation. Serum or plasma CRP levels were determined at the diagnostic laboratory SSDZ (Delft, The Netherlands) using a turbidimetric standard test provided by Orion Diagnostica, Espoo, Finland. The assay uses an antiserum against human CRP and a human CRP reference standard.
Joint destruction. Urines were collected overnight with a fine-mesh covered tray placed under the cage of each individual monkey. After precipitation of contaminants by centrifugation, the clear urine samples were stored frozen at −20°C until analysis. In unhydrolysed urine samples, collagen cross-links were determined with reversed-phase high-performance liquid chromatography (HPLC ) essentially according to Black et al. [15, 16 ] . After purification of urine samples by solid-phase extraction with CF1-cellulose, 3 ml of a 5 ml aqueous eluate were lyophilized and reconstituted in 1% (w/v) heptafluorobutyric acid (HFBA; 250 ml ). After centrifugation, 50 ml aliquots were injected into the HPLC system, consisting of a Gynkotek pump (Model 300, delivering a flow of 1.0 ml/min), a Gastor GT-103 degasser, a Promis Autosampler, and a Jasco fluorometer (Model 821 FP, excitation and emission wavelengths set at 295 and 400 nm, respectively). All equipment was obtained from Separations Analytical Instruments, Hendrik Ido Ambacht, The Netherlands. The analytical C18-column (Tosohaas ODS-80TM, 4.6×150 mm; Bester, Amstelveen, The Netherlands) was equipped with a mBondapak C18 Guard-Pak column ( WaterMillipore, Milford, MA, USA). Using a solvent select valve (Model SSV; Waters-Millipore, Bedford, MA, USA), the column was eluted for 15 min with 0.1% w/v HFBA containing 18% v/v methanol, followed by Peakmaster 3 chromatography data system (Harley per collagen molecule, assuming 300 hydroxyproline embedded in paraffin and cut into 2 mm sections. The sections were stained in HPS (haematoxylin-phloxinresidues per triple helix. saffran) or Alcian Blue-PAS (periodic acid-Schiff ).
Histology
At necropsy, the fingers and toes showing arthritic Statistics Statistical differences were determined with Student's interphalangeal (IP) joints were cut off and fixed in 4% phosphate-buffered formalin. After fixation, the t-test (unpaired) using StatWorks ( V1.2) for Macintosh computers, unless stated otherwise; bones were decalcified for 3 weeks in Kristensen's solution (17% formic acid in 1  NaOH, pH 2.2). P < 0.05 was considered significant. The correlation between CRP levels and the score for arthritis After a short wash in running tap water, the bones were trimmed longitudinally with a scalpel. After (Fig. 2C ) was determined with the Spearman rank order correlation test. another wash in running tap water for 16 h, the bones were dehydrated in an ascending series of ethanol, RESULTS followed by toluene and impregnation in liquid paraffin at 60°C. Subsequently, the fingers and toes were
Body weight measurement as a parameter of CIA expression Four Mamu-A26-negative monkeys (BB115, BB103, BB106 and BB89) were immunized with b-CII in CFA and developed a monophasic polyarthritis. As could be expected from the fact that each rhesus monkey is genetically unique, a variable disease course is found F. 2.-Plasma CRP levels in CIA-susceptible and -resistant rhesus monkeys, and the relationship of CRP with CIA severity. Eleven monkeys were immunized with b-CII/CFA; six without (A) and five F. 3.-Effect of cyclosporin A treatment on plasma CRP levels. with the dominant disease-resistance marker Mamu-A26 (B). The CRP levels (mg/l ) in venous blood plasma collected at the indicated Eight monkeys were immunized with b-CII/CFA. Four of the monkeys were treated with cyclosporin A to suppress CIA (solid time points were determined with routine diagnostic methods. Twenty-three monkeys, immunized with b-CII/CFA, were clustered lines), 25 mg/kg/day s.c. between days 7 and 25 a.i. and 12.5 mg/kg s.c. between days 25 and 32. Four other monkeys were sham treated based on the clinical diagnosis of their disease severity (C ). The values of individual monkeys are given as dots, whereas the mean (dotted lines). At the indicated time points, the monkeys were weighed (A) and venous blood plasma CRP levels (B) were values per group are given with a bar. The numbers of animals in each group (n) are also indicated in the figure. determined.
in individual monkeys (Fig. 1A) . Figure 1B shows that are addressed: (i) whether serum CRP levels reflect the severity of arthritis and (ii) whether CRP as disease each monkey loses substantial body weight during the development of CIA. Monkeys BB115 and BB103 marker is sensitive to anti-arthritic therapy, in this case with cyclosporin A. showed early onset of the first disease symptoms and substantial weight loss between 20 and 40 days after Figure 2A and B show plasma CRP levels measured at different time intervals after immunization with immunization (a.i.). They were therefore characterized as early responders. Monkeys BB89 and BB106 b-CII in six Mamu-A26-negative and five Mamu-A26-positive monkeys. It is shown that high CRP levels developed arthritis at a much later stage, and were therefore characterized as late responders.
were confined to Mamu-A26-negative, CIA-susceptible monkeys ( Fig. 2A) . CRP values remained at the backRemission of arthritis in rhesus monkeys is difficult to assess due to severe deformation of affected joints ground level in Mamu-A26-positive, CIA-resistant monkeys ( Fig. 2B) . For a second analysis, 23 monkeys and because the natural dark red colour of the skin obscures the reddening of inflamed joints. The recovery of the panel were clustered based on the clinical diagnosis of CIA severity made by an experienced of the body weight of monkeys BB115 and BB103 from day 40 a.i. points to disease remission. During veterinarian in the field following the criteria described in Materials and methods. The highest measured CRP the study period, no remission of the arthritis was observed in BB89, whereas the very severe disease in values during the disease period in groups of animals with similar macroscopic disease symptoms are given BB106 necessitated euthanasia before remission could occur.
in Fig. 2C . The results show that monkeys with a more severe disease course are characterized by higher CRP peak values.
Serum CRP levels as a quantitative parameter of inflammation in CIA monkeys
We have reported previously that cyclosporin A, when administered well after immunization but before In clinical practice, CRP is a commonly used parameter to monitor periods of active arthritis in RA the onset of CIA, suppressed the expression of arthritis in four out of four monkeys [17] . Figure 3A shows the patients. In the following experiment, the questions one time point in only one of four cyclosporin-treated monkeys (8719). Statistical analysis showed that CRP levels at time points 14, 28 and 42 days are significantly decreased body weight in the four control monkeys higher in the sham-treated group than in the cyclospowhich developed arthritis. Baseline values at −7, 0 rin-treated group (P < 0.02). Furthermore, CRP levels and 14 days are significantly higher than the body in the cyclosporin-treated group at time points 14, 28 weights recorded at later time points (P < 0.001). The and 42 days were not significantly elevated as compared body weights remained stable in three of the cyclospoto baseline values recorded at the onset of the rin-treated monkeys, confirming the absence of arthexperiment. We conclude from these data that (i) elevated plasma ritis, although in one non-arthritic monkey a decreased CRP levels mark periods of active CIA, (ii) the absolute CRP level reflects the severity of arthritis and (iii) CRP as a disease marker is sensitive to arthritis suppression with cyclosporin A.
Histology of CIA-affected IP joints
The most common manifestation of CIA in rhesus monkeys is inflammatory swelling of the PIP joints of fingers and toes. Involvement of the large joints, elbows and knees is not always observed macroscopically. At autopsy, however, synovitis and joint destruction can often been observed in joints that appeared unaffected macroscopically. Figure 4 shows representative examples of the healthy IP joints of a non-arthritic monkey (A/B), a monkey killed during a period of active arthritis (C/D) and one killed after the active disease period ( E/F/G). In a healthy joint (A), the synovium is inactive, the cartilage has a smooth surface and the bone marrow has a normal appearance (B). During active CIA, ingrowth of the synovium into the joint cavity is observed (C ) with pannus formation overlying the cartilage, which then has a rough surface (D). In some areas, subchondral degradation of bone by cells that have probably infiltrated from the bone marrow is observed as well (D). In advanced CIA, the cartilage is almost completely lost ( E, F ) and active bone remodelling by osteoblasts and osteoclasts is taking place (G). Cells resembling osteoclasts (a) and osteoblasts (b) are indicated in Fig. 4G with arrows.
These data show that joint erosion is an important feature of CIA in rhesus monkeys. We have therefore investigated markers for cartilage and bone erosion in the disease model.
Urinary excretion rates of collagen cross-links as a marker of joint erosion in CIA monkeys
The collagen cross-links HP and LP are present in different relative quantities in joint tissues, such as bone, cartilage, tendons, etc. ( Table II ) . The highest levels of cross-links were found in articular cartilage. In the cartilage, >98% of the pyridinoline cross-links consisted of HP; the HP/LP ratio was 55. In tendons, synovium and ligaments, an intermediate HP/LP ratio was found, between 10 and 25. The lowest HP/LP ratio, four, was found in bone. To test the assumption that urinary excretion of cross-links reflects joint destruction, four male monkeys, two Mamu-A26+ve were immunized with b-CII/CFA. Three monkeys period (Fig. 5A) .
The urinary excretion rates of the collagen crosslink HP had already increased in responder animals Maximal excretion rates were observed around the fifth week in BB58 and BB78, and in BB67 in the BB58, BB67 and BB78 early in the disease, namely in the third week after immunization ( Fig. 5B; paired eighth week, excretion rates being 8 to 16-fold higher than baseline values. Excretion rates of LP followed a t-test comparing week 2 and week 3: P < 0.001). similar time course, although no significant increase that in the two early responder monkeys BB115 and BB103 (see also Fig. 1 ) an early peak level of CRP was observed yet in week 3 ( Fig. 5C ). LP levels started to increase in the fourth week after immunization and was already found in the serum at~20-25 days after immunization (Fig. 6A) . At that time, a substantial reached a peak level in the sixth (BB58 and BB78) or eighth week (BB67), after which the levels of this weight loss was also recorded in these animals ( Fig. 1) . The peak levels of urinary HP excretion in these two established marker of bone turnover declined. The maximal increase in excretion rates of LP was significmonkeys were found 10 (BB115) or 20 (BB103) days later. In the late responder monkey BB89, a different antly smaller (4-to 7-fold; mean 5.0 ± 1.3) than that of HP (8-to 16-fold; mean 12.3 ± 3.3; P < 0.05). The situation was found, namely a gradual increase in the plasma CRP level and at the same time a gradual larger increase in excretion rate of HP compared to LP also becomes apparent by analysing the change in increase in the urinary excretion rate of HP. This observation suggests that in hyperacute CIA, inflam-HP/LP ratio with time. In the responder animals BB58, BB67 and BB78, HP/LP ratios from week 3 onward mation is already found before substantial joint destruction takes place. In the more chronic pro-(12.2 ± 1.9) were significantly higher than values obtained during the first 2 weeks of the study (mean gressing form of CIA, of which monkey BB89 is an example, inflammation and joint destruction may be 5.3 ± 2.6; P < 0.001). In the disease-resistant monkey BB77, no change in rates of cross-link excretion was more closely associated. observed throughout the study. DISCUSSION In a second experiment, the time course of plasma CRP levels and urinary excretion rates of HP was
The rhesus monkey CIA model is of particular interest as a test system for the safety and efficacy monitored in the three CIA-susceptible monkeys BB115, BB103 and BB89. The results in Fig. 6 show evaluation of new therapeutic modalities based on human-specific biotechnology products for which rodent models are invalid, such as monoclonal antibodies, cytokines or cytokine antagonists [4] . To be able to assess the value of a new therapy and to compare its efficacy with existing ones, the effect on the disease process must be measured not only in a qualitative, but also in a quantitative, manner. A semiquantitative scoring system that is based on clinical diagnosis [5] has several limitations for the rhesus monkey. First, at autopsy, inflammation and cartilage erosion can be found in joints which appeared normal at clinical inspection. Second, the natural dark-red colour of the rhesus monkey skin obscures the reddening of inflamed joints. Hence, the onset of inflammation can only be estimated on the basis of warmth and swelling of the joint. For the same reasons, remission of the arthritis is difficult to assess because the joint deformation by bone remodelling masks reduction of the swelling and disappearance of the reddening of the joints cannot be seen. In conclusion, there is a need for objective and quantitative parameters for monitoring the arthritis. In this study, the validity of three parameters for different aspects of the disease was investigated, namely the body weight as a measure of general disease expression, plasma CRP levels to monitor inflammation and urinary excretion rates of collagen cross-links representing destruction of joint tissues.
Body weight as a clinical marker in CIA
In small rodent models, the onset of CIA is characterized by a substantial decrease in the body weight, whereas disease remission is associated with recovery of the body weight. The results of this study show that also in rhesus monkey the onset of CIA is associated with a decrease in body weight. It is shown that periods plasma CRP levels. When the inflammation subsides, At the indicated times, the monkeys were weighed, a clinical diagnosis as deduced from low plasma CRP levels, the body of CIA was made (both see Fig. 1 ). In addition, serum CRP levels (A) and urinary excretion rates of HP (B)were determined. weight increases. In addition, when the arthritis was suppressed with cyclosporin A, reduction of the body Since type II collagen in cartilage contains 9-fold higher levels of HP than type I collagen in bone, one weight was also prevented. Such observations lead us to the conclusion that body weight measurement promight speculate that urinary excretion rates of HP may (partly) reflect cartilage degeneration. Cross-sectional vides a sensitive indicator for the onset and remission of CIA.
studies revealed that excretion rates of HP and LP are increased in patients with joint diseases such as rheumatoid arthritis and osteoarthritis [27] [28] [29] . However, CRP as a marker of joint inflammation CRP is a marker of the acute-phase reaction which the HP/LP ratio does not deviate from the normal value of about four. Thus, excretion rates of collagen is commonly used in clinical studies in RA patients as a marker of active inflammation [18] [19] [20] [21] . The results cross-links in joint diseases are considered to be indicative of bone turnover and not of degradation of other of the present study show that high CRP levels are confined to arthritic monkeys. A necessary condition joint tissues. In our longitudinal study, which has the advantage of having baseline values of cross-link excrefor CRP as a quantitative disease marker in rhesus monkey CIA is that it should (i) reflect the disease tion before the onset of arthritis, urinary excretion of HP increased twice as much as that of LP ( Fig. 5B  severity and (ii) respond to anti-arthritic therapy. It is shown in this report that higher peak levels of CRP and C ). Thus, in this animal model, about half of the amount of HP excreted in urine may be derived from are associated with more severe expression of arthritis. Furthermore, treatment with cyclosporin A for supbone. The other half probably results from degradation of other joint tissues, in particular the cartilage, which pression of CIA clearly reduced plasma CRP levels.
is almost completely eroded in advanced CIA ( Fig. 4) . This was confirmed by evaluation of the HP/LP ratio.
Collagen cross-links as markers of joint erosion
Thus far, efficacy evaluation of experimental therapIn the non-responder monkeys, the HP/LP ratio was around five throughout the experiment. In contrast, in ies on joint destruction in rhesus monkeys has been difficult to perform. As in RA patients, radiographic the three responder monkeys, the initial HP/LP ratios of five doubled within 3 weeks to about 12. In addition, analysis of affected joints can be performed, but clear alterations can be found only in advanced stages of urinary excretion rates of HP are already significantly elevated at week 3 after immunization, which is earlier the disease. An additional problem is that the cartilage, which is the main target tissue of CIA, is not directly than excretion rates of LP start to increase. This is consistent with observations in rodent CIA models visible with radiography. Magnetic resonance imaging (MRI ) is more suitable for direct visualization of the that cartilage erosion starts earlier than erosion of bone. articular cartilage (personal unpublished observation), but this is a time-consuming and costly procedure, and
An important question in the recent literature is how closely inflammation and joint destruction are not suitable for routine monitoring of large numbers of animals. Finally, the necessity to transport the connected. It is generally assumed that joint destruction is initiated by synovitis, but becomes uncoupled at monkeys to an MRI facility and the long sedation time during scanning are a serious inconvenience to later stages of the disease [29] [30] [31] [32] . Looking in more detail at inflammation (BB58 < BB67 # BB78) vs the monkeys. Hence, we have searched for a more convenient and non-invasive method.
cross-link excretion (BB78 < BB67 < BB58), our data suggest that CIA inflammation and destruction are Several markers have been studied in synovial fluid as feasible indicators of joint destruction [22] [23] [24] . also uncoupled processes in rhesus monkey. The main conclusion is that by monitoring, in addiWhereas many of these parameters serve their purpose in synovial fluid, systemic monitoring of joint destruction to the clinical evaluation, the body weight, serum CRP concentration and urinary excretion of the collation (in blood or urine) is hampered by the fact that these markers are extensively metabolized, resulting in gen cross-link HP, the processes of joint inflammation and joint destruction can be described in quantitative low or undetectable concentrations in serum or urine. The pyridinoline cross-links in collagen (HP and LP) terms. This adds substantial strength to the rhesus monkey CIA model as a test system for evaluating the do not show this limitation and represent degradation of mature extracellular matrix. We therefore focused efficacy of new therapies. on the urinary excretion rates of these cross-links as indicators of joint destruction. A The present study shows that the urinary excretion
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